116 related articles for article (PubMed ID: 26071853)
1. Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma.
Harris WB
Mol Aspects Med; 2015 Nov; 45():47-54. PubMed ID: 26071853
[TBL] [Abstract][Full Text] [Related]
2. Racial Disparities and Preventive Measures to Renal Cell Carcinoma.
Sims JN; Yedjou CG; Abugri D; Payton M; Turner T; Miele L; Tchounwou PB
Int J Environ Res Public Health; 2018 May; 15(6):. PubMed ID: 29843394
[TBL] [Abstract][Full Text] [Related]
3. Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations.
Callahan CL; Schwartz K; Corley DA; Ruterbusch JJ; Zhao WK; Shuch B; Graubard BI; Rothman N; Chow WH; Silverman DT; Purdue MP; Hofmann JN
Cancer Causes Control; 2020 Jan; 31(1):85-93. PubMed ID: 31782041
[TBL] [Abstract][Full Text] [Related]
4. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
Patel HD; Kates M; Pierorazio PM; Allaf ME
Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
[TBL] [Abstract][Full Text] [Related]
5. Identifying Genetic and Biological Determinants of Race-Ethnic Disparities in Stroke in the United States.
Kamin Mukaz D; Zakai NA; Cruz-Flores S; McCullough LD; Cushman M
Stroke; 2020 Nov; 51(11):3417-3424. PubMed ID: 33104469
[TBL] [Abstract][Full Text] [Related]
6. Racial difference in histologic subtype of renal cell carcinoma.
Olshan AF; Kuo TM; Meyer AM; Nielsen ME; Purdue MP; Rathmell WK
Cancer Med; 2013 Oct; 2(5):744-9. PubMed ID: 24403240
[TBL] [Abstract][Full Text] [Related]
7. Race and renal cell carcinoma stage at diagnosis: an analysis of the Surveillance, Epidemiology, and End Results data.
Lin J; Kamamia C; Shriver CD; Zhu K
Eur J Cancer Prev; 2019 Jul; 28(4):350-354. PubMed ID: 30376467
[TBL] [Abstract][Full Text] [Related]
8. Disparities in allostatic load, telomere length and chronic stress burden among African American adults: A systematic review.
Murkey JA; Watkins BX; Vieira D; Boden-Albala B
Psychoneuroendocrinology; 2022 Jun; 140():105730. PubMed ID: 35338946
[TBL] [Abstract][Full Text] [Related]
9. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.
Marchioni M; Harmouch SS; Nazzani S; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Briganti A; Shariat SF; Schips L; Karakiewicz PI
Cancer Epidemiol; 2018 Jun; 54():112-118. PubMed ID: 29715680
[TBL] [Abstract][Full Text] [Related]
10. Racial/ethnic disparities in renal cell carcinoma: Increased risk of early-onset and variation in histologic subtypes.
Batai K; Harb-De la Rosa A; Zeng J; Chipollini JJ; Gachupin FC; Lee BR
Cancer Med; 2019 Nov; 8(15):6780-6788. PubMed ID: 31509346
[TBL] [Abstract][Full Text] [Related]
11. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
[TBL] [Abstract][Full Text] [Related]
12. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
Chow WH; Shuch B; Linehan WM; Devesa SS
Cancer; 2013 Jan; 119(2):388-94. PubMed ID: 23147245
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
Rose TL; Deal AM; Krishnan B; Nielsen ME; Smith AB; Kim WY; Milowsky MI
Cancer; 2016 Oct; 122(19):2988-95. PubMed ID: 27341404
[TBL] [Abstract][Full Text] [Related]
14. BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas.
Paulucci DJ; Sfakianos JP; Yadav SS; Badani KK
Urol Oncol; 2016 Jun; 34(6):259.e9-259.e14. PubMed ID: 26854086
[TBL] [Abstract][Full Text] [Related]
15. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer disparities in African Americans.
Khawja SN; Mohammed S; Silberfein EJ; Musher BL; Fisher WE; Van Buren G
Pancreas; 2015 May; 44(4):522-7. PubMed ID: 25872128
[TBL] [Abstract][Full Text] [Related]
17. Racial disparity in incidence patterns and outcome of kidney cancer.
Vaishampayan UN; Do H; Hussain M; Schwartz K
Urology; 2003 Dec; 62(6):1012-7. PubMed ID: 14665346
[TBL] [Abstract][Full Text] [Related]
18. The effect of race and gender on the surgical management of the small renal mass.
Kates M; Whalen MJ; Badalato GM; McKiernan JM
Urol Oncol; 2013 Nov; 31(8):1794-9. PubMed ID: 22687567
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
[TBL] [Abstract][Full Text] [Related]
20. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]